Delivra Health Brands Stock Net Asset

DHBUF Stock  USD 0.01  0.0003  2.65%   
Delivra Health Brands fundamentals help investors to digest information that contributes to Delivra Health's financial success or failures. It also enables traders to predict the movement of Delivra OTC Stock. The fundamental analysis module provides a way to measure Delivra Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Delivra Health otc stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Delivra Health Brands OTC Stock Net Asset Analysis

Delivra Health's Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.

Net Asset

 = 

Current Market Value

-

Current Liabilities

More About Net Asset | All Equity Analysis

Current Delivra Health Net Asset

    
  11.59 M  
Most of Delivra Health's fundamental indicators, such as Net Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Delivra Health Brands is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
Competition

Based on the recorded statements, Delivra Health Brands has a Net Asset of 11.59 M. This is much higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The net asset for all United States stocks is notably lower than that of the firm.

Delivra Net Asset Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Delivra Health's direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Delivra Health could also be used in its relative valuation, which is a method of valuing Delivra Health by comparing valuation metrics of similar companies.
Delivra Health is currently under evaluation in net asset category among its peers.

Delivra Fundamentals

About Delivra Health Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Delivra Health Brands's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Delivra Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Delivra Health Brands based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in Delivra OTC Stock

Delivra Health financial ratios help investors to determine whether Delivra OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Delivra with respect to the benefits of owning Delivra Health security.